Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA

Neuropharmacology

Volumn 56, Issue 3, 2009, Pages 647-652

  Oksman, Mari ^a   Tanila, Heikki ^a,b   Yavich, Leonid ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Synuclein; A30P mutation; Behaviour; Dopamine overflow; L DOPA; Nucleus accumbens shell

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN A30P; CARBIDOPA; DOPAMINE; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG SENSITIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENOTYPE; LOCOMOTION; MALE; MEDIAL FOREBRAIN BUNDLE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; STEREOTYPY; STRAIN DIFFERENCE; TRANSGENIC MOUSE; WILD TYPE;

ALPHA-SYNUCLEIN; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC WIRING; LEVODOPA; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NUCLEUS ACCUMBENS;

EID: 58749112730     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.11.004     Document Type: Article

References (24)

1. Abeliovich A., Schmitz Y., Farinas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., and Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25 (2000) 239-252
2. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain Res. 287 (1983) 173-196
3. Fleming S.M., Salcedo J., Hutson C.B., Rockenstein E., Masliah E., Levine M.S., and Chesselet M.F. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience 142 (2006) 1245-1253
4. Fredriksson A., Plaznik A., Sundstrom E., Jonsson G., and Archer T. MPTP-induced hypoactivity in mice: reversal by L-dopa. Pharmacol. Toxicol 67 (1990) 295-301
5. Gomez-Isla T., Irizarry M.C., Mariash A., Cheung B., Soto O., Schrump S., Sondel J., Kotilinek L., Day J., Schwarzschild M.A., Cha J.H., Newell K., Miller D.W., Ueda K., Young A.B., Hyman B.T., and Ashe K.H. Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol. Aging 24 (2003) 245-258
6. Henry B., Crossman A.R., and Brotchie J.M. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Exp. Neurol 151 (1998) 334-342
7. Jensen P.H., Nielsen M.S., Jakes R., Dotti C.G., and Goedert M. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273 (1998) 26292-26294
8. Kim D.S., Szczypka M.S., and Palmiter R.D. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci 20 (2000) 4405-4413
9. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
10. Lee J., Di Marzo V., and Brotchie J.M. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats. Neuropharmacology 51 (2006) 557-565
11. Lotharius J., and Brundin P. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum. Mol. Genet. 11 (2002) 2395-2407
12. Lotharius J., and Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci 3 (2002) 932-942
13. Mannistö P.T., Lang A., Rauhala P., and Vasar E. Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression. Eur. J. Pharmacol 274 (1995) 229-233
14. Miller D.W., and Abercrombie E.D. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats. J. Neurochem 72 (1999) 1516-1522
15. Neumann M., Kahle P.J., Giasson B.I., Ozmen L., Borroni E., Spooren W., Muller V., Odoy S., Fujiwara H., Hasegawa M., Iwatsubo T., Trojanowski J.Q., Kretzschmar H.A., and Haass C. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J. Clin. Invest 110 (2002) 1429-1439
16. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2000), Academic Press, San Diego
17. Perez R.G., Waymire J.C., Lin E., Liu J.J., Guo F.L., and Zigmond M.J. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci 22 (2002) 3090-3099
18. Rockenstein E., Mallory M., Hashimoto M., Song D., Shults C.W., Lang I., and Masliah E. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J. Neurosci. Res. 68 (2002) 568-578
19. Tehranian R., Montoya S.E., Van Laar A.D., Hastings T.G., and Perez R.G. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J. Neurochem 99 (2006) 1188-1196
20. Yavich L. Two simultaneously working storage pools of dopamine in mouse caudate and nucleus accumbens. Br. J. Pharmacol 119 (1996) 869-876
21. Yavich L., and MacDonald E. Dopamine release from pharmacologically distinct storage pools in rat striatum following stimulation at frequency of neuronal bursting. Brain Res. 870 (2000) 73-79
22. Yavich L., Tanila H., Vepsäläinen S., and Jäkälä P. Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci 24 (2004) 11165-11170
23. Yavich L., Oksman M., Tanila H., Kerokoski P., Hiltunen M., van Groen T., Puolivali J., Mannisto P.T., Garcia-Horsman A., and MacDonald E. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein. Neurobiol. Dis 20 (2005) 303-313
24. Yavich L., Jakala P., and Tanila H. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J. Neurochem 99 (2006) 724-732